Abstract
The majority of patients with hypothyroidism who are treated with thyroid hormone replacement to maintain serum TSH levels within the population reference range experience complete resolution of their hypothyroid symptoms. However, a significant minority have persistent symptoms and express dissatisfaction with their treatment. These patients usually benefit from seeing attentive and compassionate providers who listen carefully to their concerns and work with them to explore solutions. They should be evaluated for other coexistent autoimmune and systemic disorders and be encouraged to engage in healthy lifestyle practices. It is often productive to carefully explain that nonspecific symptoms are common in the population and are often not related to thyroid disease. A polymorphism (Thr92Ala) of the deiodinase 2 enzyme, which converts thyroxine (T4) to triiodothyronine (T3) in the brain, is present in approximately 16% of the population. These patients have been reported in one study to respond better to combination therapy with levothyroxine (LT4) and liothyronine (LT3); however genetic testing for this polymorphism is expensive and not recommended. Current clinical practice guidelines stress that replacement with LT4 is the treatment of choice for patients with hypothyroidism; however, a trial of combination LT4 and LT3 or of desiccated thyroid extract with maintenance of serum TSH levels within the reference range is considered reasonable to determine if these patients may experience better symptom relief than they have had with LT4 monotherapy.
Keywords
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Chaker L, Bianco AC, Jonklass J, Peeters RP. Hypothyroidism. Lancet. 2017;390(10101):1550–62.
McDermott MT. Hypothyroidism. In: Cooper DS, Sipos J, editors. Medical management of thyroid disease. 3rd ed. New York, NY: Informa Healthcare; 2019. (in press).
McDermott MT. Overview of the clinical manifestations of hypothyroidism. In: Braverman LE, Cooper DS, editors. Werner & Ingbar’s the thyroid: a fundamental and clinical text. 11th ed. Philadelphia: Lippincott Williams & Wilkins; 2019. (in press).
Zulewski HK, Muller B, Exer P, Miserez AR, Staub JJ. Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. J Clin Endocrinol Metab. 1997;82:771–6.
Carle A, Pedersen IB, Knudsen N, et al. Hypothyroid symptoms and the likelihood of overt thyroid failure: a population-based case-control study. Eur J Endocrinol. 2014;171:593–602.
Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, Pessah-Pollack R, For the American Association of Clinical Endocrinologists and American Thyroid Association Task Force on Hypothyroidism in Adults Study Groups, et al. Clinical practice guidelines for hypothyroidism in adults; cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18(6):988–1028.
Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, Cooper DS, For the American Thyroid Association Task Force on Thyroid Hormone Replacement, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on thyroid hormone replacement. Thyroid. 2014;24(12):1670–751.
Guglielmi R, Frasoldati A, Zini M, Grimaldi F, Gharib H, Garber JR, Papini E. Italian association of clinical endocrinologists statement-replacement therapy for primary hypothyroidism: a brief guide for clinical practice. Endocr Pract. 2016;22(11):1319–26.
Santoro N, Braunstein GD, Butts CL, Martin KA, McDermott M, Pinkerton JV. Compounded bioidentical hormones in endocrinology practice: an Endocrine Society scientific statement. J Clin Endocrinol Metab. 2016;101(4):1318–43.
Negro R, Valcavi R, Agrimi D, Toulis KA. Levothyroxine liquid solution versus tablet for replacement in hypothyroid patients. Endocr Pract. 2014;20(9):901–6.
Bruncato D, Scorsone A, Saura G, Ferrara L, Di Noto A, Aiello V, Fleres M, Provenzano V. Comparison of TSH levels with liquid formulation versus tablet formulations of levothyroxine in the treatment of adult hypothyroidism. Endocr Pract. 2014;20(7):657–62.
Vita R, Saraceno G, Trimarchi F, Benvenga S. Switching levothyroxine from the tablet to the oral solution formulation corrects the impaired absorption of levothyroxine induced by proton-pump inhibitors. J Clin Endocrinol Metab. 2014;99(12):4481–6.
Biondi B, Wartofsky L. Treatment with thyroid hormone. Endocr Rev. 2014;35(3):433–512.
McAninch EA, Bianco AC. The history and future treatment of hypothyroidism. Ann Intern Med. 2016;164(1):50–6.
Winther KH, Cramon P, Watt T, Bjorner JB, Ekholm O, Feldt-Rasmussen U, Groenvold M, et al. Disease-specific as well as generic quality of life is widely impacted in autoimmune hypothyroidism and improves during the first six months of levothyroxine therapy. PLoS One. 2016;11(6):e0156925.
Lee SY, Braverman LE, Pearce EN. Changes in body weight after treatment of primary hypothyroidism with levothyroxine. Endocr Pract. 2014;20(11):1122–8.
Thvilum M, Brandt F, Almind D, Christensen K, Brix TH, Hegedüs L. Increased psychiatric morbidity before and after the diagnosis of hypothyroidism: a nationwide register study. Thyroid. 2014;24(5):802–8.
Quinque EM, Villinger A, Kratzsch J, Karger S. Patient-reported outcomes in adequately treated hypothyroidism – insights from the German versions of ThyQoL, ThySRQ and ThyTSQ. Health Qual Life Outcomes. 2013;11:68.
Samuels MH, Kolobova I, Smeraglio A, Peters D, Janowsky JS, Schuff KG. The effects of levothyroxine replacement or suppressive therapy on health status, mood, and cognition. J Clin Endocrinol Metab. 2014;99(3):843–51.
Samuels MH, Kolobova I, Smeraglio A, Niederhausen M, Janowsky JS, Schuff KG. Effect of thyroid function variations within the laboratory reference range on health status, mood, and cognition in levothyroxine-treated subjects. Thyroid. 2016;26(9):1173–84.
Peterson SJ, Cappola AR, Castro MR, et al. Degrees of satisfaction and coexistent diseases in those responding to a survey exploring perceptions about treatment of hypothyroidism. Thyroid. 2018 Jun;28(6):707–21.
Samuels MH, Kolobova I, Smeraglio A, Peters D, Purnell JQ, Schuff KG. Effects of levothyroxine replacement or suppressive therapy on energy expenditure and body composition. Thyroid. 2016;26(3):347–55.
Samuels MH, Kolobova I, Antosik M, Niederhausen M, Purnell JQ, Schuff KG. Thyroid function variation in the normal range, energy expenditure, and body composition in L-T4-Treated subjects. J Clin Endocrinol Metab. 2017;102(7):2533–42.
Ito M, Miyauchi A, Kang S, Hisakado M, Yoshioka W, Ide A, Kudo T, et al. Effect of the presence of remnant thyroid tissue on the serum thyroid hormone balance in thyroidectomized patients. Eur J Endocrinol. 2015;173(3):333–40.
Peterson SJ, McAninch EA, Bianco AC. Is a normal TSH synonymous with “Euthyroidism” in levothyroxine monotherapy? J Clin Endocrinol Metab. 2016;101(12):4964–73.
Ott J, Promberger R, Kober F, Neuhold N, Tea M, Huber JC, Hermann M. Hashimoto’ s thyroiditis affects symptom load and quality of life unrelated to hypothyroidism: a prospective case-control study in women undergoing thyroidectomy for benign goiter. Thyroid. 2011;21(2):161–7.
Boelaert K, Newby PR, Simmonds MJ, Holder RL, Carr-Smith JD, Heward JM, Manji N, et al. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med. 2010;123(2):183.e1–9.
Roy A, Laszkowska M, Sundstrom J, Lebwohl B, Green PH, Kä mpe O, Ludvigsson JF. Prevalence of celiac disease in patients with autoimmune thyroid disease: a meta-analysis. Thyroid. 2016;26(7):880–90.
Bollerslev J, Rejnmark L, Marcocci C, Shoback DM, Sitges-Serra A, van Biesen W, Dekkers OM, European Society of Endocrinology. European Society of Endocrinology Clinical Guideline: treatment of chronic hypoparathyroidism in adults. Eur J Endocrinol. 2015;173(2):G1–20.
Panicker V, Saravanan P, Vaidya B, Evans J, Hattersley AT, Frayling TM, Dayan CM. Common variation of in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients. J Clin Endocrinol Metab. 2009;94(5):1623–9.
Appelhof BC, Peeters RP, Wiersinga WM, Visser TJ, Wekking EM, Huyser J, Schene AH, et al. Polymorphisms in type 2 deiodinase are not associated with well-being, neurocognitive functioning, and preference for combined thyroxine/3,5,3′-triiodothyronine therapy. J Clin Endocrinol Metab. 2005;90(11):6296–9.
Castagna MG, Dentice M, Cantara S, Ambrosio R, Maino F, Porcelli T, Marzocchi C, et al. DIO2 Thr92Ala reduced deiodinase-2 activity and serum T3 levels in thyroid deficient patients. J Clin Endocrinol Metab. 2017;102(5):1623–30.
Hoang TD, Olsen CH, Mai VQ, Clyde PW, Shakir MK. Desiccated thyroid extract compared with levothyroxine in the treatment of hypothyroidism: a randomized, double-blind, crossover study. J Clin Endocrinol Metab. 2013;98(5):1982–90.
Shresta RT, Malabanan A, Haugen BR, Levy EG, Hennessey JV. Adverse event reporting in patients treated with thyroid hormone extract. Endocr Pract. 2017;23(5):566–75.
Jonklaas J, Burman KD. Daily administration of short-acting liothyronine is associated with significant triiodothyronine excursions and fails to alter thyroid-responsive parameters. Thyroid. 2016;26(6):770–8.
Wiersinga WM, Duntas L, Fadeyev V, Nygaard B, Vanderpump MPJ. 2012 European Thyroid Association (ETA) guidelines: the use of L-T4 + L-T3 in the treatment of hypothyroidism. Eur Thyroid J. 2012;1(2):55–71.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
McDermott, M.T. (2019). Persistent Hypothyroid Symptoms Despite Adequate Thyroid Hormone Replacement. In: McDermott, M. (eds) Management of Patients with Pseudo-Endocrine Disorders. Springer, Cham. https://doi.org/10.1007/978-3-030-22720-3_23
Download citation
DOI: https://doi.org/10.1007/978-3-030-22720-3_23
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-22719-7
Online ISBN: 978-3-030-22720-3
eBook Packages: MedicineMedicine (R0)